Skip to main content
. 2016 Sep 5;4:89. doi: 10.3389/fcell.2016.00089

Table 1.

List of FISH panels and probes for hematopoietic and lymphoid tumors.

Gene (G-band) Probe Design Myeloid leukemia Lymphocytic leukemia Lymphoma MM/MGUS MPD
CML MDS AML CLL B-ALL T-ALL
CKS1B (1q21), CDKN2C (1p32) DCE 1p/1q+
PBX1 (1q23.3), TCF3 (19p13.3) DCDF t(1;19) t(1;19)
ALK (2p23) DCBAP ALK
MECOM (3q26) DCBAP inv(3)
BCL6 (3q27) DCBAP BCL6
D4Z1 (4cen), D10Z1 (10cen), D17Z1 (17cen) TCE +4/10/17
PDGFRA (4q12) DCBAP PDGFRA
FGFR3 (4p16.3), IGH (14q32) DCDF t(4;14)
TAS2R1 (5p15.31), EGR1 (5q31) DCE 5q−/−5
PDGFRB (5q33) DCBAP PDGFRB PDGFRB
MYB (6q23), D6Z1 (6cen) DCE 6q−
RELN (7q22), TES (7q31) DCE 7q−/−7
TCRB (7q34) DCBAP TCRB
FGFR1 (8p11) DCBAP FGFR1
RUNX1T1 (8q21), RUNX1 (21q22) DCDF t(8;21)
cMYC (8q24) DCBAP cMYC
cMYC (8q24), D20S108 (20q12) DCE +8/20q−
PAX5 (9p13.2) DCBAP PAX5
CDKN2A (9p21), D9Z3 (9cen) DCE 9p− 9p−
ABL (9q34), BCR (22q11) DCDF t(9;22) t(9;22) t(9;22)
CCND1 (11q13), IGH (14q32) DCDF t(11;14) t(11;14)
ATM (11q22), TP53 (17p13) DCE 11q−/17p−
KMT2A (11q23) DCBAP KMT2A KMT2A KMT2A
ETV6 (12p13), RUNX1 (21q22) DCDF t(12;21)
DLEU1 (13q14), D13S25 (13q34) DCE 13q−
DLEU1 (13q14), D13S25 (13q34), D12Z3 (12cen) TCE 13q−/+12
TCRA/D (14q11) DCE TCRA
IGH (14q32) DCBAP IGH IGH IGH
IGH (14q32), BCL2 (18q21) DCDF t(14;18)
SNRPN (15q11.2), TP53 (17p13) DCE +15/17p−
PML (15q24), RARA (17q21) DCDF t(15;17)
MYH11 (16p13), CBFB (16q22) DCDF inv(16)
MALT1 (18q21) DCBAP MALT1
CRLF2 (Xp22.33) DCBAP CLFR2

DCE,dual-color enumerate; TCE, tri-color enumerate; DCBAP, dual-color break apart; DCDF, dual-color double fusion; CML, Chronic myeloid leukemia; MDS, Myelodysplastic syndrome; AML, Acute myeloid leukemia; CLL, Chronic lymphocytic leukemia; B-ALL, B-cell acute lymphocytic leukemia; T-ALL, T-cell acute lymphocytic leukemia; MM/MGUS, Multiple myeloma/Monoclonal mopathy of undetermined significance; MPD, Myeloproliferative disorder. Shaded for recurrent abnormalities detected by a primary FISH panel, unshaded for secondary FISH probes for specific abnormalities. For references see (Hu et al., 2014; Liehr et al., 2015), and (Mikhail et al., 2016).